Novo Nordisk has entered into separate research collaborations with Omega and Cellarity.
Novo Nordisk has entered into separate research collaborations with Omega and Cellarity. The Omega collaboration will leverage its proprietary platform technology to develop an epigenomic controller designed to enhance metabolic activity. The Cellarity collaboration aims to unravel novel biological drivers…